# Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical Trials

> **NCT01332448** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Orlistat 120
- **DRUG:** Orlistat 60

## Key facts

- **NCT ID:** NCT01332448
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2017-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01332448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01332448, "Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical Trials". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01332448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*